INTRODUCTION
Astrocytes are key players in the regulation of synapse strength and microcirculatory blood flow via changes in free intracellular Ca 2+ at their peri-synaptic compartments and peri-vascular endfeet. Despite astrocytes' privileged position to integrate distinct inputs arising from both neurons and the microcirculation, our understanding of the factors governing astrocyte activation is limited in active animals during events that increase brain blood flow. In fact, coordinating brain activity with the delivery of blood must rely on local synapses, neuromodulatory networks, and vascular signals that operate dynamically across behavioral states, but how astrocyte activity fits into this complex control system is unclear. Examining Ca 2+ signals in separate astrocyte compartments along with vasculature dynamics in behaving mice will provide insights into how these glial cells participate in brain energetics and plasticity.
Many studies have examined astrocyte Ca 2+ signals in response to an experimental increase in neuronal activity. Evidence primarily from acute brain slices demonstrated that a change in astrocyte free Ca 2+ was sufficient to actuate arteriole diameter (Girouard et al., 2010; Gordon et al., 2008; Mulligan and MacVicar, 2004; Rosenegger et al., 2015; Straub et al., 2006; Takano et al., 2006) and change synaptic efficacy (Fiacco and McCarthy, 2004; Gordon et al., 2009; Kang et al., 1998; Parpura and Haydon, 2000) . Although in vivo work constitutes a significant technical advance, the majority of studies are limited in four primary aspects: (1) a preponderance of astrocyte soma or bulk astrocyte Ca 2+ measurements with a lack of examination of the arbor or endfoot (Ding et al., 2013; Paukert et al., 2014; Schulz et al., 2012; Schummers et al., 2008; Takano et al., 2006) ; (2) use of electrical stimulation rather than a natural stimulus (Lind et al., 2013; Nizar et al., 2013; Schulz et al., 2012) ; (3) uncertainty regarding the origin of the Ca 2+ signal from the use of bulk-loaded dyes (Lind et al., 2013; Schummers et al., 2008; Takano et al., 2007; Winship et al., 2007) ; and (4) use of anesthesia (Lind et al., 2013; Nizar et al., 2013; Otsu et al., 2015; Schulz et al., 2012; Schummers et al., 2008; Takano et al., 2007; Winship et al., 2007) or sedation (Bonder and McCarthy, 2014) , which may misrepresent relationships between neural activity, astrocyte Ca 2+ changes, and hemodynamics (Masamoto et al., 2009; Thrane et al., 2012; Tran and Gordon, 2015a) . Examining astrocytes in fully awake and active animals is critical because signaling pathways involving both the brain and the microcirculation can crosstalk in a realistic manner. Integration of local glutamatergic signaling with global noradrenergic (Ding et al., 2013; Paukert et al., 2014) or cholinergic (Chen et al., 2012; Takata et al., 2011) projections have been shown to enhance astrocyte Ca 2+ signals. Additionally, work conducted in slices or under anesthesia in vivo suggests that astrocyte endfeet may sense changes in arteriole diameter (Kim et al., 2015; Kozlov et al., 2006) . This further highlights the need to examine astrocytes in active preparations where microvascular diameter as well as local and long-range neuronal signaling are constantly changing. Recent reports regarding awake mice show novel Ca 2+ dynamics in astrocytes (Agarwal et al., 2017; Bindocci et al., 2017; Paukert et al., 2014; Srinivasan et al., 2015; Stobart et al., 2018) but with no relationships to hemodynamics and with little new information provided regarding the factors that contribute to glutamate-evoked signals. Here we performed in vivo twophoton imaging on active mice to examine the Ca 2+ activity patterns of cortical astrocytes during functional hyperemia.
RESULTS
Whisker Stimulation Induced Fast Functional Hyperemia followed by Delayed Astrocyte Ca 2+ Elevation To investigate astrocyte activation under realistic conditions, we used our awake in vivo two-photon imaging model (Tran and Gordon, 2015b) adapted from previous technical advances (Dombeck et al., 2007; Shih et al., 2012) to image astrocyte free Ca 2+ and vasomotor responses to contralateral whisker stimulation (5-s air puff). Trained, head-restrained mice were free to ambulate on a passive air-supported spherical treadmill ( Figure 1 ) and were video-monitored during fluorescence imaging to capture various behaviors, such as natural whisking and running, as well as to verify whisker deflection with an air puff ( Figure 1A ). We first employed Slc1a3-Cre/ERT x RCL-GCaMP3 mice to achieve a genetically encoded Ca 2+ indicator in astrocytes. This permitted the separate assessment of Ca 2+ dynamics in the soma, arbor, and endfoot of individual astrocytes surrounding penetrating arterioles in the barrel cortex (layers 1-3). The vasculature was visualized by labeling the blood plasma with Rhod B-dextran (Figures 1 B and 1C) . In response to whisker stimulation, functional hyperemia was consistently observed by the presence of fast arteriole dilation (onset = 0.8 s; Dd/d = 11.7% ± 1.1%, n = 155 trials), which was followed by a delayed and widespread astrocyte Ca 2+ transient in the arbor (onset = 3.3 s; DF/F = 13.5% ± 2.5%, n = 151 trials), soma (onset = 3.3 s; DF/F = 47.9% ± 10.5%, n = 64 trials), and endfoot (onset = 3.9 s; DF/F = 46.8% ± 8.5%, n = 147 trials) (31 mice; Figures 1D and 1E; Video S1). These onset times were extrapolated from the averaged data (STAR Methods); thus, we also performed a trial-based analysis (STAR Methods) from a random selection of 90 trials (all onset time calculations were trial-based from here onward). This showed relatively slow Ca 2+ onsets for the soma (3.6 ± 0.4 s), arbor (3.9 ± 0.3 s), and endfoot (4.6 ± 0.4 s), all of which were significantly slower than the 2.2 ± 0.2 s onset for arteriole dilation (p < 0.05). This temporal profile of astrocyte Ca 2+ is in agreement with work in anesthetized mice (Nizar et al., 2013) . However, in contrast to the low incidence of events described previously ($10%), our data showed that 65% of the trials exhibited a rise in endfoot Ca 2+ in active mice. Furthermore, 15% of these 90 trials showed arteriole dilation without a surge in Ca 2+ , 7% with an endfoot Ca 2+ rise without dilation, and 13% of trials without any response ( Figure 1M ). Summary astrocyte Ca 2+ data (Figure 1 E) included all experimental trials and did not exclude failures; thus, the responses were relatively reliable.
We tested a shorter whisker stimulation duration and found that a 2-s air puff produced a similar arteriole dilatory response but with a less frequent endfoot Ca 2+ signal (56% versus 65%) with a smaller magnitude (28.3% ± 10.5% versus 74.4% ± 16.7%, n = 12 trials, 7 mice, p = 0.03; Figures 1G and 1H ) compared with a 5-s air puff, suggesting that the length of stimulation facilitates astrocyte engagement. We next delivered a 5-s air puff to the vibrissae that were ipsilateral to the imaging window to drive transcallosal functional hyperemia. This triggered significantly smaller arteriole dilation (Dd/d = 12.2% ± 5.4% versus 28.4% ± 2.2%) with little astrocyte Ca 2+ signal (DF/F = 8.6% ± 2.9% versus 145.0% ± 18.2%, n = 13 trials, 5 mice).
Notably, because ipsilateral vibrissa stimulation failed to cause widespread astrocyte activation, this suggested that animal startle was minimal. Finally, we performed a control experiment where we puffed air away from the contralateral whiskers, not to deflect the vibrissae but to preserve the puffing sound. This had no effect on diameter (Dd/d = 7.65% ± 4.48%) or astrocyte Ca 2+ (DF/F = 0.73% ± 2.90%, p > 0.05, n = 8 trials, 3 mice; Figures 1I and 1J) , and suggested there was little auditory influence on our measurements. These experiments indicated that the arteriole dilation and Ca 2+ signals observed from whisker stimulation were due to whisker-related processing in the barrel. Although GCaMP3 allows for unambiguous detection of Ca
2+
events from astrocyte compartments, the number of astrocytes exhibiting fluorescence and the signal-to-noise ratio of each cell achieved via knockin Cre-Lox crosses is inferior to a bulk-loaded synthetic Ca 2+ indicator. We repeated the above experiment using the relatively high-affinity probe Rhod-2 AM, which shows preferential loading into astrocytes (Takano et al., 2006) . This strategy was used with blood plasma labeled with fluorescein isothiocyanate (FITC)-dextran ( Figures 1K and 1L ). An equivalent result was achieved as whisker stimulation elicited fast functional hyperemia (onset = 2.1 ± 0.3 s, Dd/d = 20.6% ± 2.1%) that preceded the onset of a Rhod-2 astrocyte Ca 2+ signal in the arbor (onset = 4.1 ± 0.5 s, DF/F = 4.6% ± 2.0%), soma (onset = 5.2 ± 0.4 s, DF/F = 34.6% ± 11.1%, n = 41 trials), and endfoot (onset = 6.3 ± 0.5 s, DF/F = 28.4% ± 6.1%) (n = 61 trials, 18 mice; Figure 1M ; Video S2).
We next compared these responses to astrocytes expressing GCaMP6s using Aldh1l1-Cre/ERT2 x RCL-GCaMP6s (Ai96) mice. This was to improve both the magnitude of the DF/F and the recombination efficacy (Srinivasan et al., 2016) . Indeed, the magnitudes of the arbor and endfoot Ca 2+ signals were larger to 5-s whisker stimulation (GCaMP3 endfoot Ca 2+ DF/F = 64.9% ± 12.5%, n = 69 trials; 31 mice versus GCaMP6s endfoot Ca 2+ DF/F = 169.6% ± 44.5%, n = 17 trials; 5 mice, p = 0.001; Figures 2A and 2B) ; however, the temporal profiles of arteriole dilation and astrocyte Ca 2+ were similar to our other approaches (GCaMP6s dilation onset: 2.7 ± 0.3 s versus GCaMP3 dilation onset: 2.2 ± 0.2 s; p = 0.1; GCaMP6s endfoot Ca 2+ onset: 6.0 ± 0.8 s versus GCaMP3 endfoot Ca 2+ onset: 4.6 ± 0.4 s; p = 0.1). Previous work indicated that sensory stimulation initiates electrical conduction in capillaries (Longden et al., 2017) and triggers low-branch-order capillaries to dilate (Biesecker et al., 2016; Hall et al., 2014) showed a significantly faster onset time compared with periarteriole endfeet (GCaMP3 capillary endfoot Ca 2+ onset: 3.0 ± 0.5 s, n = 29 trials, 11 mice versus GCaMP3 arteriole endfoot Ca 2+ onset: 4.6 ± 0.4 s, n = 90 trials, 31 mice, p = 0.01; Figure 2F ).
In these experiments, most of the capillaries were greater than three branch orders from the zero-order penetrator, and we did not detect an increase in capillary diameter to whisker stimulation at this level in the network (À0.5% ± 0.7%, n = 41 trials, 11 mice, p = 0.5), consistent with previous results (Cai et al., 2018 functional hyperemia onset (arteriole initiation = 0.8 s), this suggests that this particular delayed Ca 2+ signal is not an initiator of the blood flow increase. However, we cannot exclude a role for ultrafast (Lind et al., 2013) or small Ca 2+ transients in astrocytes (Bindocci et al., 2017; Stobart et al., 2018) Behavioral states such as arousal, attention, and locomotion have been proposed to prime astrocytes in response to local neuronal activity in the neocortex (Paukert et al., 2014; Takata et al., 2011) . These findings implicate an interaction between neuromodulatory networks and local glutamatergic signaling in controlling astrocyte Ca 2+ activity, with analogous processes occurring in organisms as simple as flies (Ma et al., 2016) . However, whether this relationship is also observed between astrocyte endfeet and the microvasculature during sensation-evoked blood flow increases in awake mice remains unexplored. We analyzed our large dataset to test whether the animal's behavior would predict some of the variability we observed in astrocyte responses. Examining a subset of the data (41 trials encompassing 25 arterioles and astrocytes from 21 mice), where we could clearly categorize a given animal's action, revealed three primary behavioral states that were associated with whisker stimulation: quiet-to-running, in which animals were resting prior to but started running immediately after the stimulation onset (13 trials); continuous running, identifying animals that were running prior to and remained running during the stimulation period (21 trials); and continuous quiet, indicating animals that remained quiet before, during, and after whisker stimulation (7 trials) ( Figure 3A ). Histogram and scatterplot analyses of the response onset and peak of all 41 trials demonstrated tightly clustered arteriole dilation data, whereas endfoot Ca 2+ responses were variable between the three different behavioral states ( Figures 3B-3F) . Notably, the behavioral state did not affect the onset time of arteriole dilation (quiet-to-running, 1.7 ± 0.4 s; continuous running, 2.3 ± 0.3 s; continuous quiet, 1.9 ± 0.3 s; p > 0.05; Figure 3G ) or the onset of endfoot Ca 2+ rise (quiet-to-running, 3.9 ± 0.6 s;
continuous running, 5.7 ± 0.7 s; continuous quiet, 3.9 ± 0.8 s; p > 0.05; Figure 3H ). Although the peak amplitude of dilation was also not influenced by different behavioral states (quiet-torunning, 27.1% ± 3.2%; continuous running, 26.2% ± 2.6%; continuous quiet, 39.5% ± 8.7%; p > 0.05; Figure 3I ), we observed a significant difference between the peak amplitude of endfoot Ca 2+ transients. In particular, when whisker stimulation triggered running, a significantly stronger endfoot Ca 2+ signal was observed (quiet-to-running, DF/F = 241.9% 30.4%) compared with when the animal was constantly running (DF/F = 133.5% ± 20.8%, p = 0.006). Notably, continuous quiet mice, suggestive of an un-engaged behavior, generated the smallest Ca 2+ transients (DF/F = 17.5% ± 2.9%) that were significantly different from the other two conditions (p = 0.02, p < 0.001; Figure 3J ). These data suggest that the magnitude of the late astrocyte endfoot Ca 2+ signal during neurovascular coupling is potentiated by movement.
Volitional Behaviors Cause Functional Hyperemia and Delayed Endfoot Ca 2+ Signals
Running is tightly associated with natural whisking in mice and rats (Sofroniew and Svoboda, 2015) , a relationship we also observed in our data ( Figure 1D ). The barrel cortex is reciprocally connected with whisker motor regions (Deschê nes et al., 2012) , suggesting that the act of whisking may drive neural activity and blood flow changes in the barrel. Therefore, we aimed to examine arteriole diameter changes and endfoot Ca 2+ activity in response to volitional running where the animal naturally whisked (e.g., a quiet-to-running behavior without whisker stimulation). We analyzed activities associated with volitional movement that lasted more than 2 s and that were separated from any previous volitional movement ( Figure 4A ; Video S3) (n = 23 trials, 10 mice). This may be particularly important because natural whisking and experimental whisker deflection have been demonstrated to rely on distinct afferent inputs and signal processing mechanisms within the somatosensory cortex (Arabzadeh et al., 2005; Krupa et al., 2004) . Interestingly, volitional running and natural whisking induced a robust functional hyperemia that was again followed by a delayed astrocyte Ca 2+ transient ( Figures 4B-4F ). Although natural whisking and the deflection of whiskers via air puff generated arteriole dilation with a similar onset (natural: 1.5 ± 0.2 s versus stimulation: 1.7 ± 0.4 s, p = 0.7; Figure 4G ), the peak dilation was significantly larger for the volitional behavior (natural: 43.4% ± 5.7% versus stimulation: 27.1% ± 3.2% versus p = 0.02; Figure 4H ). Additionally, the onset time of the volitional running-induced endfoot Ca 2+ increase was significantly more delayed than that of whisker deflection (natural: 6.8 ± 0.7 s versus stimulation: 3.9 ± 0.6 s, p = 0.008; Figure 4I ). Furthermore, when the animal chose to go from being quiet to running, the peak endfoot Ca 2+ signal generated was significantly smaller than that observed when the animal went from quiet to running in response to whisker stimulation (natural: 123.8% ± 30.1% versus stimulation: 241.9% ± 30.4%, p = 0.004; Figure 4J ). These data provide evidence that experimental whisker deflection and natural whisking result in different measurable outcomes regarding both arteriole diameter and astrocyte Ca 2+ transients in the barrel cortex of the awake animal.
Glutamatergic Signaling Is Necessary for the Sensation-Evoked Delayed Astrocyte Ca 2+ Rise
Afferent glutamatergic input from the thalamus to the neocortex is an important initiation signal for functional hyperemia in anesthetized animals (Norup Nielsen and Lauritzen, 2001 ) and can mediate synaptically evoked astrocyte Ca 2+ transients in the barrel cortex and the olfactory bulb (Lind et al., 2013; Otsu et al., 2015) . To test for a contribution from this pathway in awake mice, we topically administered the ionotropic, non-NMDA receptor antagonist DNQX (500 mM) to the surface of the neocortex. By employing a cranial window in which the cover glass was perforated with multiple $175-mm diameter through-holes, we could maintain the same basic imaging configuration and stability as our previous control trials while being able to superfuse compounds ( Figure 5A ). Performing a paired comparison of control trials (superfused aCSF) to trials in the presence of DNQX, we found that DNQX only marginally reduced the evoked arteriole dilation (Dd/d = 31.6% ± 4.0% versus 27.6% ± 4.1%, p = 0.9; Figures 5B and 5C) but robustly inhibited Ca 2+ transients in the endfoot (DF/F = 90.6% 17.3% versus 31.4% ± 15.6%, n = 21 trials; 9 mice, p = 0.005; Figures 5B and 5D ). NMDA receptor activation is also a key pathway in functional hyperemia (Fergus and Lee, 1997) and in synaptically evoked astrocyte Ca 2+ elevations (Dani and Smith, 1995; Mehina et al., 2017) . Superfusing the competitive NMDA receptor (NMDAR) antagonist DL-APV (1 mM) had similar effects to DNQX, producing little attenuation of arteriole dilation (Dd/d = 24.6% ± 2.0% versus 20.3% ± 2.8%, p = 0.1; Figure 5C ) while significantly decreasing the elevation in endfoot Ca 2+ (DF/F = 77.5% ± 12.9% versus 43.7% ± 11.2%, n = 27 trials; 5 mice, p = 0.02; Figure 5D ). The fact that arteriole dilation was largely maintained by DNQX and APV was likely the result of insufficient concentration at a depth where functional hyperemia initiates (Tian et al., 2010) . In line with this idea, we found that the same concentration of DNQX significantly attenuated naturally occurring functional hyperemia in the barrel cortex in response to a running/whisking event (Dd/d = 43.4% ± 5.6% versus 23.3% ± 4.0, n = 10 trials, 5 mice, p = 0.006). Here, one would expect a stronger contribution of associative inputs in superficial layers (Muralidhar et al., 2013) where the DNQX concentration was highest. These data demonstrate an essential role for ionotropic, non-NMDA, and NMDA glutamate receptor activation in generating the late Ca 2+ signal in astrocyte endfeet. Figures 6A and 6B ). Additionally, there was no effect on baseline arteriole tone from SC58125 (normalized baseline diameter: 83.5% ± 16.6%, n = 5, p = 0.4; Figure 6B ). To target NOS, we first used LNPLA to block nNOS (NOS1), which has 150-fold selectivity over eNOS (NOS3) (Zhang et al., 1997) . The local superfusion of LNPLA (300 mM) decreased sensory evoked arteriole dilation (control Dd/d = 20.9% ± 2.0% versus LNPLA Dd/d = 15.8 ± 4.1, p = 0.04; Figures 6C and 6D ) but was without significant effect on endfoot Ca 2+ (DF/F = 48.8% ± 11.6% versus 61.73% ± 12.4%, n = 35 trials; 5 mice, p = 0.07; Figures 6C  and 6D ). Consistent with a selective action on nNOS, we found no change to resting arteriole tone by the application of LNPLA into the barrel cortex (normalized baseline diameter: 94.7% ± 3.8%, n = 5, p > 0.9; Figure 6D ). Notably, these results were distinctly different from what we observed using the non-selective NOS inhibitor LNIO (300 mM), which has been demonstrated in some experiments to have preferential action on eNOS over nNOS (Jiang et al., 2002) . Superfusion of LNIO significantly increased basal arteriole tone (vasoconstriction) (normalized baseline diameter = 82.7% ± 5.2%, n = 4, p = 0.0003), which is consistent with the ongoing production of NO from shear-stress activated eNOS (NOS3) in the vascular endothelium (Chatterjee et al., 2015) . Furthermore, the partially constricted vessel in LNIO displayed increased peak arteriole dilation in response to whisker stimulation (control Dd/d = 26.9% ± 2.4% versus LNIO Dd/ d = 36.2% ± 3.2%, p = 0.01). Interestingly, the evoked endfoot Ca 2+ signal in LNIO was significantly reduced (control DF/F = 79.3% ± 13.9% versus LNIO DF/F = 34.8% ± 8.1%, n = 36 trials; 4 mice, p = 0.002; Figures 6E and 6F ). These data suggest that the late endfoot Ca 2+ signal is modulated by distinct blood flow control pathways, likely involving an increase in vessel-derived NO from the arteriole dilation, which is consistent with the delayed nature of the endfoot Ca 2+ signal.
Microvasculature Can Elevate Endfoot Ca

2+
Given that astrocyte endfoot Ca 2+ follows the peak of arteriole dilation and that putative eNOS blockade reduced the late endfoot Ca 2+ signal, we hypothesized that increased blood flow via increased arteriole diameter contributes to elevating endfoot Ca 2+ . A similar concept involving astrocyte sensing of intraluminal pressure pulses (Kozlov et al., 2006) or vasoconstriction from the myogenic response (Kim et al., 2015) has been forwarded, with most evidence from acute brain slices. However, little is known about how vasculature may communicate to astrocytes in awake mice. To test our hypothesis, we selectively manipulated vascular responses using chemogenetics and monitored astrocyte Ca 2+ dynamics ( Figure 7A ). Activation of endogenous Gq-coupled receptors in endothelium, such as muscarinic 5, is known to drive vasodilation in cerebral arterioles (Yamada et al., 2001 ). Therefore, we activated hM3Dq receptors expressed in vascular endothelium using Tek-Cre/ERT2 x CAG-LSL-Gq-DREADD mice. The mCitrine reporter for the Gq-DREADD showed selective vascular endothelial expression in the barrel cortex ( Figure 7B ). After verification of the mCitrine signal, mice were tail vein-injected with FITC dextran. Tissue was loaded with Rhod-2 AM to label astrocytes during window installation. Local superfusion of the hM3Dq ligand compound 21 (50 mM) generated large and sustained dilation of the penetrating arteriole (Dd/d = 30.1% ± 9.8%, p = 0.002; Figures  7C-7E ), which was followed by a delayed elevation in endfoot Ca 2+ (DF/F = 15.2% ± 7.3%, n = 10 mice, p = 0.005; Figures   7C-7E ) (onset time, 111 ± 47 s) (Video S4). This effect was not observed in animals negative for both knockin sequences (Dd/d = À1.52% ± 2.1%, DF/F = À13.4% ± 3.6% n = 5 mice, p = 0.6; Figure 7D ). Gq receptor activation in endothelium couples to NO production (Palmer et al., 1987 ); thus, we tested the role of vascular NO in these effects. In the presence of LNIO, both arteriole dilation (Dd/d = 8.1% ± 7.0%, p = 0.02) and the elevation in endfoot Ca 2+ (DF/F = À7.1% ± 5.3%, n = 10 mice, p = 0.04)
were significantly reduced during compound 21 application ( Figure 8E ). We then used optogenetics for an additional strategy to test for a direct or facilitating effect of the vasculature on astrocyte endfoot Ca 2+ dynamics. We used Tek-Cre x ArchT/EGFP mice in which vascular endothelial cells expressed a light-sensitive proton pump (Figures 8A and 8B ; Video S5). The rationale was that, when light activates ArchT, H + ions would be extruded from the endothelium, causing hyperpolarization. This would also hyperpolarize smooth muscle cells via charge transfer across myoendothelial gap junctions, causing a drop in smooth muscle cell Ca 2+ and consequent arteriole dilation (Segal, 2015) . Endothelial hyperpolarization initiates vascular electrical conduction (Domeier and , which is a component of functional hyperemia (Longden et al., 2017) . We loaded Rhod-2 AM in astrocytes and delivered 591-nm laser light onto the center of the window using an optical fiber ($1.5-mm diameter spot size). By shining the light for 1 s and titrating the laser power on successive trials, we could eventually evoke arteriole dilation (Dd/d = 7.2% ± 2.4%, p < 0.001) (laser power = 10-15 mW out of the fiber), which was followed by an increase in endfoot Ca 2+ (DF/F = 21.0% ± 7.0%, Figure 8C , left). The same experiment performed on Tek-Cre-and ArchT/EGFP-negative animals caused neither arteriole dilation (2.0% ± 3.0%, p = 0.3) nor raised endfoot Ca 2+ (À2.6% ± 1.1%, p = 0.8; n = 6 trials, 3 mice; Figure 8C, right) .
Increased blood flow causes increased shear stress along the vessel wall and augments NO production, leading to vasodilation, termed flow-induced vasodilation (Kuo et al., 1990; Rubanyi et al., 1986) . Furthermore, vascular electrical conduction and subsequent dilation are followed by a slower, endotheliumderived wave of NO release (Budel et al., 2003; Tallini et al., 2007) . Therefore, we examined the role of NO in facilitating the endfoot Ca 2+ signal in response to opto-mediated arteriole dilation. These experiments used conditional Tek-Cre/ERT2 x ArchT/EGFP mice. We first ensured a control response from arterioles and endfeet to yellow light in superfused aCSF and then examined the effect of LNIO in a paired fashion. In the presence of LNIO, we found that light-evoked arteriole dilation and endfoot Ca 2+ elevation were significantly attenuated (control Dd/d = 22.1% ± 2.1% versus LNIO Dd/d = 13.8% ± 3.6%, p = 0.06; control DF/F = 26.8% ± 8.2% versus LNIO DF/F = 3.0% ± 1.6%, n = 14 trials, 5 mice, p = 0.006; Figures  8D and 8E, left) , implicating endothelium-derived NO in the effect.
Given that endfoot Ca 2+ increased to both whisker-evoked dilation and light-induced vasodilation in an NO-dependent manner, we tested the hypothesis that each route converged onto a common eNOS pathway. For this, we measured dilation and endfoot Ca 2+ to each stimulation given alone and when combined. In Tek-Cre/ERT x ArchT/EGFP animals, whisker stimulation generated arteriole dilation (control Dd/ d = 24.0% ± 3.1%), followed by a delayed endfoot Ca 2+ signal (DF/F = 28.2% ± 5.7%, n = 14 trials, 5 mice; Figure 8E , center), and only the Ca 2+ change was sensitive to LNIO treatment (Dd/ d = 28% ± 4.3%, p = 0.5; DF/F = 13.87% ± 4.9%, n = 14 trials, 5 mice, p = 0.005; Figure 8E, center) . We then tested whether we could occlude any further increase in sensation-evoked endfoot Ca 2+ when whisker stimulation was given in the presence of light. Indeed, we found that whisker stimulation plus yellow light did not enhance endfoot Ca 2+ to a greater degree compared with either manipulation alone (light, 26.83% ± 8.2%; whisker stimulation, 28.2% ± 5.7%; whisker stimulation plus light, 39.9% ± 12.7%; n = 14 trials; 5 mice; p = 0.3; Figures 8E and 8F) . Furthermore, LNIO still decreased the evoked endfoot Ca 2+ signal in response to whisker stimulation plus light (control DF/F = 39.9% ± 12.7% versus LNIO DF/F = 5.5% ± 2.1%, n = 14 trials, 5 mice, p = 0.03; Figure 8E, right) , and the degree of this reduction was not different across all three stimulation groups (light: À77.6% ± 16.1%; whisker stimulation: À43.23% ± 17.4%; whisker stimulation plus light: À61.2% ± 20.0%, n = 14 trials, 5 mice, p = 0.5; Figure 8F ). These data suggest that arteriole-derived NO can elevate endfoot Ca 2+ and that, during functional hyperemia, this arteriole-to-endfoot pathway is recruited during sensationdriven glutamatergic input to the barrel cortex.
DISCUSSION
The model we propose is that, during functional hyperemia, glutamate is the primary driver of the delayed astrocyte Ca 2+ elevation. The presence of neuromodulators from increased arousal/locomotion and/or the presence of vascular-derived NO, facilitates the astrocyte Ca 2+ signal. DNQX and APV largely eliminated the astrocyte endfoot Ca 2+ in response to whisker stimulation or in response to a natural running/whisking event despite the fact that the vasodilation was mostly intact. We anticipate that a higher dose of APV would have decreased sensory evoked vasodilation via the NMDA-nNOS pathway by reaching deeper into the cortical mantle as other studies have reported (Busija et al., 2007; Lecrux and Hamel, 2011; Ma et al., 1996) . This is because we did observe a reduction in functional hyperemia using the nNOS blocker NPLA. However, NPLA did not reduce endfoot Ca
2+
, suggesting that the effect of APV on astrocyte Ca 2+ was not via neural NMDAR-generated NO. One way these data can be understood is the evidence that brain microvascular endothelium expresses NMDA receptors (Stobart et al., 2013) and, perhaps, that these receptors are responsible for the late endfoot Ca 2+ signal rather than synaptic NMDARs. Garthwaite et al. (1988) showed how NMDAR activation leads to the accumulation of cGMP in the brain, and, based on extracellular NO scavenging experiments, they speculated that the source of NO could be vascular rather than neuronal. How neuronally derived NO fails to affect endfoot Ca 2+ but vasculature-derived NO does may be puzzling. However, the two signaling pathways are likely spatially separated. Electron microscopy (EM) immuno-labeling showed that only 5%-10% of terminals and dendrites in the barrel cortex express nNOS, even around blood vessels (Wang et al., 2005) , suggesting that neuronally derived NO affects only targeted points on the vascular network and, thus, would likely not affect all astrocytic endfeet. Conversely, eNOS is ubiquitously expressed by vascular endothelium (Shu et al., 2015) . Furthermore, hyperpolarization of deep and small-diameter microvasculature from synaptic activity begins a retrograde conducted response that helps dilate upstream contractile vasculature. This phenomenon travels at $2 mm/s and accounts, at least partially, for fast functional hyperemia (Chen et al., 2014; Longden et al., 2017) . Notably, work from other vascular beds showed that a slower, secondary wave follows the ascending hyperpolarization, involving endothelial Ca 2+ elevation and the release of NO, which occurs on the order of $100 mm/s (Tallini et al., 2007) . Thus, one would expect a large, delayed wave of vascular NO that follows initial fast vasodilation. This is consistent with our data that describe a delayed endfoot Ca 2+ that follows vasodilation and is enhanced by NO.
One pitfall to our work is acute inflammatory effects of the cranial window. Although mice were on dexamethasone to minimize acute inflammation and brain swelling from surgery, this is an important caveat, and it is necessary to compare our findings with a thinned-skull preparation. Furthermore, our data do not examine deeper layers of the cortex. Previous work suggests that functional hyperemia is initiated in the deepest cortical layer (VI) (Uhlirova et al., 2016) and propagates up to the pial surface (Chen et al., 2014) . Capillaries may respond before penetrating arterioles during functional hyperemia (Biesecker et al., 2016; Hall et al., 2014; Longden et al., 2017) , which is somewhat consistent with our data. However, the onset of peri-capillary endfoot Ca 2+ signals was still slower than the initiation of functional hyperemia ($3.5 s versus 0.8 s). It is well defined that astroglia can sense glutamatergic synaptic transmission (Nimmerjahn et al., 2009; Schummers et al., 2008; Zonta et al., 2003) and signals arising from the noradrenergic and cholinergic systems (Bekar et al., 2008; Ding et al., 2013; Paukert et al., 2014; Takata et al., 2011) . In vivo, the release of endogenous norepinephrine and acetylcholine (ACh) is associated with arousal, attention, and vigilance (Aoki et al., 1998; Polack et al., 2013; Vaucher and Hamel, 1995) . Direct electrical stimulation of the locus coeruleus (Bekar et al., 2008; Ding et al., 2013) or nucleus basilis (Chen et al., 2012; Takata et al., 2011) or locomotion (Paukert et al., 2014) have all been shown to induce or enhance Ca 2+ transients in cortical astrocytes, which is consistent with our data. In the absence of locomotion, no whisking, and little arousal (continuous quiet), the glutamatergic thalamocortical afferents would form the primary input to the barrel cortex in response to whisker stimulation, which is consistent with the smaller degree of astrocyte activation we observed. Our data are also consistent with a lack of astrocyte signals observed in lightly sedated mice (Bonder and McCarthy, 2014) , where arousal/attention is below normal. In fact, our data showed that whisker-stimulation-initiated running (quiet-to-running)-a behavior previously known to trigger activation of Bergmann glia in the cerebellum (Nimmerjahn et al., 2009 ) and astrocytes in the visual cortex (Paukert et al., 2014) -induced strong astrocyte Ca 2+ elevation in the barrel cortex. Finally, our data point to an important role of vascular NO in a novel form of arteriole-to-endfoot communication. Kim et al. (2015) demonstrated that astrocytes display an elevation in Ca 2+ to the myogenic response via mechano-sensitive and Ca
-permeable TRPV4 channels in endfeet. However, this is a vasoconstriction to increased luminal pressure, and we were likely studying a different cell-cell pathway because it is unlikely that (1) the vasodilation we observed was the result of a systemic drop in blood pressure and (2) that the myogenic response would use the same mechanism as functional hyperemia. The pressure-TRPV4 mechanism is also proposed to go beyond affecting just astrocyte Ca 2+ and can ultimately affect neural activity (Kim et al., 2016) . It would be interesting to better understand whether the facilitation of astrocyte Ca 2+ by vascularly derived NO can affect neural/synaptic function. Recent data exploiting optogenetic control of vasculature in vivo showed that direct control of blood flow did not affect the power of the gamma band in local field potential recordings (Mateo et al., 2017) . Although this argues against the vasculo-neuronal hypothesis, other aspects of neural excitability or synaptic properties should be examined in future studies. Collectively, our data support the idea that astrocyte activation in vivo may rely on integrating signals from multiple inputs: glutamatergic synapses, neuromodulatory afferents, and vascularderived NO. This study provides a new platform to explore the role of astrocyte Ca 2+ transients in the behaving animal.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Grant Gordon (gordong@ucalgary.ca).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Animals
All animal procedures have been approved by the Animal Care and Use Committee of the University of Calgary. All studies were either performed on male C57BL/6 mice, male Slc1a3-Cre/ERT x RCL-GCaMP3 mice (Jax #012586 and #014538, Ai38), male Aldh1l1-Cre/ ERT2 x RCL-GCaMP6s mice (Jax #029655 and #024106, Ai96), male Tek-Cre x RCL-ArchT/EGFP (Jax #008863 and #021188, Ai40D), male Tek-Cre/ERT2 (EMMA 00715, via Dr. Brown C U Victoria) x RCL-ArchT/EGFP mice, or male or female Tek-Cre/ ERT2 x CAG-LSL-Gq-DREADD (Jax # 026220) mice between P30 to P60. The original background strain from the commercial vendor was used for crosses and all crosses involved heterozygote mice. Positive offspring used for experiments were heterozygotes for each gene/knock-in of interest. For the use of conditional lines (ERT or ERT2), we initiated our acute awake imaging protocol at least two weeks after the last of three consecutive tamoxifen injections (100 mg/kg, 10 mg/mL corn oil stock, Sigma, St. Louise MO USA). Injections started at p19 or up to p35. Animals were kept on a normal 12 hour light and 12 hour dark cycle and had access to food and water ad libitum. Animals were group housed until the installation of the head-bar (see below). The experimenter was not blinded to the treatment.
METHOD DETAILS
Awake In Vivo Preparation All surgeries used standard aseptic procedures, isoflurane anesthesia, with post-operative pain and infection control as previously described (Tran and Gordon, 2015b) . One week before the imaging session, a custom head bar was surgically installed without performing a craniectomy and the animal was then returned to a new home cage to recover for two days (single housing from this point onward). The mouse then began training on a passive air-supported styrofoam ball treadmill under head-restraint (two 30 min sessions on consecutive days) and was habituated to contralateral vibrissae air puff once every minute for 5 s using a picospritzer III (General Valve Corp., Fairfield, USA) under near-infrared illumination. The animal was then allowed to rest for two days in their home cage. On the imaging day, a $3x3mm cover glass (thickness #0) was installed over the primary somatosensory cortex with bone and dura removed.
Calcium Indicator loading
In C57BL/6 mice, Rhod-2 AM (15mM, Biotium, Hayward CA USA) ACSF solution containing 0.2% DMSO and 0.006% Pluronic acid was applied to the brain surface for 45 minutes. The solution was replenished to maintain submersion of the brain, and then washed with ACSF for 10 minutes before sealing the window with coverglass.
Vessel Indicators
Fluorescein isothiocyanate (FITC)-dextran (MW 2,000,000, Sigma) or rhodamine B isothiocyanate (RhodB)-dextran (MW 70,000, Sigma) was tail vein injected (100-200mL of 2.3% (w/v) solution in saline) to visualize the blood plasma. Before imaging the animal recovered on the treadmill with its head immobilized for 30 minutes.
Two-Photon Fluorescence Microscopy
Fluorescence images were obtained using a custom built in vivo two-photon microscope (Rosenegger et al., 2014) fed by a tunable Ti:sapphire laser (Coherent Chameleon, Ultra II, $4 W avg power, 670-1080 nm, $80 MHz, 140 fs pulse width), equipped with GaAsP PMTs (Hamamatsu, Japan) and controlled by open-source ScanImage software (https://wiki.janelia.org/). We used a Nikon 16X, 0.8NA, 3mm WD objective lens or a Zeiss 40X, 1.0NA, 2.5mm WD objective lens. Rhod-2 was excited at 850 nm and GCaMP3 at 920 nm. Green fluorescence signals were filtered using a 525/50nm BP, and orange/red light was filtered using a 605/70nm BP (Chroma Technology, Bellows Falls VT USA). Bidirectional xy raster scanning was used at a frame rate of 0.98 to 7.81Hz.
Behavior Capture A near infrared LED (780 nm) and camera were used to capture simple behaviors such as resting, running and whisking concurrently with two-photon fluorescence imaging for all experimental trials at a frame rate of 14 Hz.
Whisker Stimulation
For whisker stimulation, a 5 s air puff to the contralateral whiskers was applied using as little air pressure as possible that visibly deflected the whiskers (same as training). The air output was divided to two mounted glass capillary tubes that aim at separate groups of vibrissa in an attempt to stimulate as many whiskers as possible without impacting the face. Penetrating arterioles were identified via their upstream parent pial arterioles, their undulations in diameter, and the appearance of a thick vessel wall.
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Light Stimulation
For optogenetic experiments, 591nm light was used to activate ArchT using a fiber optic coupled DPSS laser (IkeCool, 2355 Westwood Blvd, Los Angeles, US). The fiber (200 mm diameter, 0.22 NA end) was positioned using a manual micromanipulator (Luigs and Neumann, Germany) with a $1.5mm laser spot on the center of the window. A 1 s light pulse of 10-15mW avg power was used.
Pharmacology
For topical superfusion, a custom coverglass with pre-drilled through-holes (7 holes, 175 mm diameter) (Laser Micromachining Ltd) was installed. ACSF was superfused at $2ml/min using a pressurized carbogen delivery system (95% O 2 , 5% CO 2 ). ACSF contained (in mM): NaCl, 126; KCl, 2.5; NaHCO 3 , 25; CaCl 2 , 1.3; MgCl 2 , 1.2; NaH 2 PO 4 , 1.25; glucose, 10; pH 7.4. After stable control data was achieved, pharmacological agents were superfused for 30 minutes prior to testing. All antagonists and agonists were purchased from Tocris BioScience and high concentration stock solutions were made in water following solubility recommendations (except for SC58125 which was dissolved in DMSO; final DMSO concentrations did not exceed 0.1%). DNQX disodium salt (cat# 2312); D,L-AP5 sodium salt (cat# 3693); SC58125 (cat# 2895); LNPLA (N u -Propyl-L-arginine hydrochloride)(cat# 1200); L-NIO dihydrochloride (cat# 0546). The DREADD ligand Compound 21 dihydrochloride was purchased from HelloBio.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data Analysis
All data was processed using ImageJ. Movement artifacts in the xy plane were corrected for using the template_matching plugin. The 3D viewer plugin was used to perform three-dimensional rendering of the microvascular network. Ca 2+ responses were calculated as DF/F = (F t -F rest )/F rest x100, where F t was the fluorescence at a given time and F rest was the averaged 2 s baseline fluorescence prior to stimulation. The average extrapolated onset time was estimated by fitting a tangent line to the rising slope of the averaged data and calculating the x-intercept. Trial-based changes were defined as gray value or area that rose above 3 x SD of baseline fluctuations, lasting for at least 0.5 s in individual trials. For trial-based onset times, we used the time point at which the signal from a single trial rose 3 x SD above baseline fluctuation after stim onset. Arteriole diameter (Dd/d) was calculated using the same general formula above for DF/F, and was quantified by obtaining a lumen area for every image by thresholding and using particle analysis in ImageJ. Animal behavior video data was analyzed offline and manually assigned a particular activity using techniques previously described (Tran and Gordon, 2015b ) and converted into a binary or trinary scale.
Machine Learning
To calculate RBC flux, we used the Trainable Weka Segmentation tool plugin available in Fiji (Arganda-Carreras et al., 2017; Schindelin et al., 2012) to classify connected image pixels as either 'red blood cell' (RBC) or 'background' on the basis of shape, texture and intensity. Briefly, we: 1) trained a Fast Random Forest classifier on a representative training set consisting of % 2% of total frames in each stack using default training features and parameters; 2) applied the classifiers to the selected ROIs in the source stacks; 3) used a custom Fiji macro to analyze and write to file the number of individual particles in the 'RBC' class. Segmentation output was also manually assessed for consistency and accuracy of classification, and the training set was expanded to include % 5% of total frames, as necessary.
Stats
Statistical analysis used a paired or unpaired t test, or one-way ANOVA as appropriate. Statistical n constituted a single experimental trial (such as whiskers stimulation or light stimulation) or a single superfusion experiment (such as compound 21 application) while imaging an astrocyte and arteriole (or capillary) pair. Either a single astrocyte and arteriole pair was examined in a single mouse or two separated astrocyte and arteriole pairs were examined in a single mouse. In each experimental group, at least 3 mice were used. The n for each experiment (trials and mice) is reported in the results section. Data are expressed as means ± SEM. Significance thresholds were: *p < 0.05, **p < 0.01, ***p < 0.001
